| [1] |
Zhang Bixia, Ding Jianghua.
Immunotherapy for EGFR-mutant non-small cell lung cancer after EGFR-TKI acquired resistance
[J]. Journal of International Oncology, 2023, 50(2): 97-101.
|
| [2] |
Zhou Ye, Yu Yan.
MET14 exon skipping mutation and non-small cell lung cancer
[J]. Journal of International Oncology, 2021, 48(6): 366-369.
|
| [3] |
Hong Li, Wang Yu, Zhang Qi, Lyu Chengfang.
Nilotinib in first-line treatment of chronic myeloid leukemia
[J]. Journal of International Oncology, 2020, 47(1): 56-59.
|
| [4] |
Zheng Liping, Chen Yidan, Zhang Nan, Quan Wen, Du Junxiang, Liang Cuiwei, Gong Wuxing.
Application value of serum LDH in advanced non-small cell lung cancer patients treated with EGFR-TKI
[J]. Journal of International Oncology, 2019, 46(6): 337-341.
|
| [5] |
Sun Yueqin, Li Aimin, Luo Yue, Song Zhenghui, Zhuang Xuefen, Dai Guanqi, Liu Xinhui.
Efficacy prediction and molecular mechanism of thyroid hormone levels and multi-target TKI therapy for renal cell carcinoma and hepatocellular carcinoma
[J]. Journal of International Oncology, 2019, 46(5): 303-306.
|
| [6] |
Long Lili1, Liang Yanling2, Zhang Xingmei2, Shi Yusheng3 .
Treatment of non-small cell lung cancer with EGFR-TKI
[J]. Journal of International Oncology, 2019, 46(2): 105-108.
|
| [7] |
Shen Jingxia, Han Bin, Wang Shuying, Kang Haili, Wang Lidong, Liu Xuhui, Cui Qinggui.
Clinical efficacy of S-1 combined with gefitinib in the treatment of advanced NSCLC with EGFR-TKI acquired drug resistance
[J]. Journal of International Oncology, 2019, 46(12): 723-727.
|
| [8] |
Qu Liyan, Kang Xiaoyan, Song Xia.
Appliation of the combination of antiangiogenic agents and EGFR-TKIs in advanced NSCLC treatment
[J]. Journal of International Oncology, 2017, 44(1): 57-59.
|
| [9] |
Huang Yan, Cheng Dan, Yang Jiyuan.
Targeted therapies for gastrointestinal cancer
[J]. Journal of International Oncology, 2017, 44(1): 71-74.
|
| [10] |
WU Xia, FENG Guo-Sheng.
Application of EGFR-TKI in locally advanced nonsmall cell lung cancer
[J]. Journal of International Oncology, 2016, 43(4): 312-314.
|
| [11] |
Zheng Lei, Song Zhengbo, Zhang Yiping.
Therapy for advanced nonsmall cell lung cancer using icotinib hydrochloride
[J]. Journal of International Oncology, 2014, 41(1): 49-52.
|
